Patents
Patents for C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
04/2005
04/13/2005EP1521750A1 Novel macrocycles for the treatment of cancer diseases
04/07/2005US20050075332 Tricyclic compounds with antiviral activity
04/06/2005CN1195526C Medicinal products containing antimer pure beta-D-dioxypentacyclic nucleoside
04/06/2005CN1195514C Metabolites of ecteinascidin 743
03/2005
03/31/2005US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response
03/29/2005US6872841 Etoposide analogs and methods of use thereof
03/15/2005US6867334 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743
03/02/2005EP1077698B1 Metabolites of ecteinascidin 743
02/2005
02/23/2005CN1585772A Chemokine receptor antagonists and methods of use thereof
02/16/2005EP1506204A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
02/10/2005WO2005012281A1 Neuroprotective benzo[1,3]oxathol-2-ones
02/10/2005CA2533475A1 Neuroprotective benzo[1,3]oxathol-2-ones
02/09/2005CN1188416C Oxathiepino [6,5-b]dihydropyridines,and related compositions and preparation methods
01/2005
01/27/2005WO2005007099A2 Pkb inhibitors as anti-tumor agents
01/13/2005WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia
01/13/2005WO2004096805A3 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
01/13/2005WO2004087650A3 Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
01/13/2005CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia
01/12/2005EP1496060A1 Antitumoral analogs of ET-743
12/2004
12/23/2004US20040259896 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions
12/16/2004WO2004096805A9 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
12/16/2004CA2524376A1 Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
12/14/2004US6831076 Epothilons C and D, preparation and compositions
12/01/2004EP1481975A1 Inhibitors of farnesyl protein transferase
11/2004
11/25/2004WO2004069149A3 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
11/23/2004CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/17/2004EP1289999B1 Antitumoral analogs of et-743
11/11/2004WO2004096805A2 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
11/11/2004WO2004096139A2 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/11/2004WO2004056879A8 Spirotetrathiocarbamates and spirooxothiocarbamates
11/11/2004CA2523426A1 Aza spiro alkane derivatives as inhibitors of metalloproteases
10/2004
10/28/2004US20040215015 Sulfonated derivatives of perylenetetracarboxylic acid dibenzimidazole sulfoderivatives anisotropic films for liquid crystals
10/27/2004EP1471056A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
10/21/2004WO2004058144A3 Antibacterial agents
10/21/2004WO2004056879A3 Spirotetrathiocarbamates and spirooxothiocarbamates
10/14/2004WO2004087650A2 Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
10/07/2004US20040198981 Tricyclic dihydroquinoline derivatives,method for preparing same and pharmaceutical compositions containing same
10/06/2004CN1534026A Condensed quinazoline derirative used as tyrosine kinase inhibitor
10/05/2004US6800656 Tricyclic compounds and method of treating herpes virus
09/2004
09/23/2004WO2004000859A3 Etoposide analogs and methods of use thereof
09/23/2004US20040186291 dissolving gases of triethylenediamine in solvents selected form acyclic alcohols-2+ or ethers of these alcohols, then treating with adsorbers such as activated carbon or ion exchangers; purification; storage stability
09/16/2004US20040180934 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
09/16/2004US20040180917 Novel tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing the same
08/2004
08/31/2004CA2098076C Imidate prodrugs of pharmaceutically useful anticonvulsant sulfamates
08/25/2004EP1448566A2 Chemokine receptor antagonists and methods of use thereof
08/19/2004WO2004069149A2 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
08/19/2004CA2515102A1 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
08/12/2004DE10303696A1 Entfärbung und Farbstabilisierung von TEDA-Lösung Decolorization and color stabilization of TEDA solution
08/10/2004US6774132 Spirooxindole derivatives that act as analgesics
08/04/2004EP1443048A1 Decolorization and color stabilization of TEDA-solutions
07/2004
07/28/2004EP1440973A2 Epothilone derivatives, preparation and use
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/15/2004WO2004058144A2 Antibacterial agents
07/14/2004CN1157189C Semi-synthetic ecteinascidins
07/08/2004WO2004056879A2 Spirotetrathiocarbamates and spirooxothiocarbamates
07/07/2004CN1511161A Novel tricyclic dikydro-quinolin derivatives, method for preparing same and pharmaceutical compositions containing same
07/07/2004CN1511158A Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
06/2004
06/15/2004US6750214 Quinoline and quinazoline compounds useful in therapy
06/09/2004EP1426375A2 Analgesic spiroindole derivatives
06/09/2004DE10255660A1 New macrocycles useful for the treatment of cancer
06/03/2004US20040106676 Water-soluble etoposide analogs and methods of use thereof
05/2004
05/06/2004WO2004037830A1 Substituted benzol[e] [1,4] oxazino[3,2-g] isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
05/06/2004US20040087800 Spirooxindole derivatives are analgesics for the treatment of chronic pain.
05/06/2004US20040087634 Antitumor agents; plant safening agents
05/06/2004CA2502484A1 Substituted benzol[e] [1,4] oxazino[3,2-g] isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
05/05/2004CN1493576A Chiral diphosphorus compound and its transition metal compounding product
04/2004
04/29/2004WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
04/14/2004EP1202994B1 New compounds
04/08/2004WO2004018481A3 Gossypol derivatives, production methods thereof and uses of same
03/2004
03/24/2004EP1400527A1 Chiral diphosphorus compounds and transition metal complexes thereof
03/24/2004EP1399455A2 Novel tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
03/24/2004CN1142923C 12,13-modified epothilone derivatives
03/11/2004US20040048883 Novel fused quinazoline derivatives useful as tyrosine kinase inhibitors
03/10/2004EP1395590A2 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]indole derivatives as prostaglandin d2 receptor antagonists
03/04/2004WO2004018481A2 Gossypol derivatives, production methods thereof and uses of same
03/04/2004DE10241256A1 New tetrahydrofuran bisphosphines useful for preparing transition metal complexes useful as catalysts for preparing stereoisomer-enriched compounds, e.g. pharmaceuticals and agrochemicals
02/2004
02/18/2004EP1389210A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
02/05/2004DE10232094A1 5-Thiaepothilone und 15-disubstituierte Epothilone 5-Thiaepothilone and 15-disubstituted epothilones
01/2004
01/29/2004US20040019051 Eating disorders of a disturbed or impaired fundus such as dyspepsia, early satiety, bloating and anorexia; e.g.,1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone
01/22/2004WO2004007492A1 Novel macrocycles for the treatment of cancer
01/22/2004WO2004007483A1 Novel macrocycles for the treatment of cancer diseases
01/22/2004WO2004007476A1 Gesellschaft für biotechnologische forschung mbh (gbf)
01/22/2004CA2491422A1 Novel macrocycles for the treatment of cancer diseases
01/08/2004US20040006126 For therapy of cancer
01/06/2004US6673772 Dipeptide compounds and their use as antiviral agents
12/2003
12/31/2003WO2004000859A2 Etoposide analogs and methods of use thereof
12/30/2003CA2099970C Composition for curing sjoegren syndrome disease
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/04/2003US20030225120 Dihydropyridine soft drugs, and related compositions and methods
11/2003
11/27/2003WO2003097649A2 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/27/2003US20030220332 Useful in the treatment of inter alia benign prostatic hyperplasia
11/27/2003CA2485214A1 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
10/2003
10/14/2003US6632807 (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide
10/09/2003WO2003082830A1 Novel fused quinazoline derivatives useful as tyrosine kinase inhibitors
10/09/2003US20030191104 Therapy for carbohydrate metabolism disorders
09/2003
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444566A Imidazolyl derivatives
09/23/2003US6624189 Byrostatin analogues, synthetic methods and uses
1 2 3 4 5 6 7 8 9 10 11